Brain Health Supplements Market by Age Group (Children, Adults, and Elderly), Product (Herbal Extract, Vitamins & Minerals, and Natural Molecules), Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-Aging, Sleep & Reco

Published Feb 22, 2022

Length 288 Pages

SKU # ALMR17117457

Description

Brain Health Supplements Market by Age Group (Children, Adults, and Elderly), Product (Herbal Extract, Vitamins & Minerals, and Natural Molecules), Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-Aging, Sleep & Recovery, and Anxiety), Supplement Form (Tablets, Capsules, and Others), and Sales Channel (Supermarkets & Hypermarkets, Drug Stores, Online Stores, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

The global brain health supplement market was valued at $ 7,653.4 million in 2020, and is projected to reach $ 19,730.1 million by 2030, registering a CAGR of 9.9% from 2021 to 2030

Brain health supplements are herbal products used to improve brain functions and cognitive activities. Brain health supplements includes herbal extracts, vitamins, minerals, and other natural components. The herbal plants such as Bacopa monniera and Withania somnifera help to enhance memory and possess neuroprotective effects.

Increase in prevalence of brain diseases such as Alzheimer’s and dementia drives the growth of brain health supplements market. For instance, as per the data published by the World Health Organization (WHO), in September 2021, more than 55 million people were suffering from dementia worldwide, and are nearly 10 million new cases are reported every year. Furthermore, aged individuals are highly prone to memory disorders, due to aging effect. Thus, increase in geriatric population propels the growth of brain health supplements market.

In addition, rise in awareness about neural health contributes toward the growth of market. Furthermore, increase in stress among people boosts the market growth. For instance, in December 2021, the World Economic Forum reported that the workers in the U.S. and Canada recorded the highest level of daily stress. This increases the demand for brain health supplements, thereby propelling the growth of the market. However, poor awareness about brain disease is expected to limit the growth of market.

The brain health supplements market is segmented into age group, product, application, supplement form, sales channel, and region. On the basis of age group, the market is classified into children, adults, and elderly. By product, it is categorized into herbal extract, vitamins & minerals, and natural molecules. The herbal extract segment is further classified into Ginseng, Ginkgo biloba, Curcumin, Lions mane, Bacopa monnieri, and other herbal extracts. The vitamins & minerals segment is subdivided into vitamin B, vitamin C & E, and other vitamins & minerals. The natural molecules segment is subcategorized into acetyl-l-carnitine, alpha GPC, citicoline, docosahexaenoic acid (DHA), huperzine-A, and other natural molecules. The applications covered in the study include memory enhancement, mood & depression, attention & focus, longevity & anti-aging, sleep & recovery, and anxiety. By supplement form, the market is mainly divided into tablets, capsules and others. By sales channel, it is categorized into supermarkets & hypermarkets, drug stores, online stores, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Allscripts Healthcare Solutions, Inc., Cerner Corporation, Computer Programs and Systems, Inc., CureMD Corporation, eClinicalWorks, Epic Systems Corporation, General Electric Company, Greenway Health, LLC, Meditech, and Praxis EMR.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an in-depth analysis of the global brain health supplements market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Brain health supplements market growth.

KEY MARKET SEGMENTS

By Age Group

Children
Adults
Elderly

By Product

Herbal Extract
Ginseng
Ginkgo Biloba
Curcumin
Lions Mane
Bacopa Monnieri
Other Herbal Extracts
Vitamins & Minerals
Vitamin B
Vitamin C & E
Other vitamins & minerals
Natural Molecules
Acetyl-L-carnitine
Alpha GPC
Citicoline
Docosahexaenoic Acid (DHA)
Huperzine-A
Other Natural Molecules

By Application

Memory Enhancement
Mood & Depression
Attention & Focus
Longevity & Anti-aging
Sleep & Recovery
Anxiety

By Supplement Form

Tablets
Capsules
Others

By Sales Channel

Supermarkets & Hypermarkets
Drug Stores
Online Stores
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY MARKET PLAYERS

Accelerated Intelligence Inc.
AlternaScript LLC
Natroll, LLC
HVMN Inc.
KeyView Labs, Inc.
Liquid Health, Inc.
Natural Factors Nutritional Products Ltd.
Onnit Labs, LLC
Purelife Bioscience Co., Ltd.
Quincy Bioscience, LLC

CHAPTER 1: INTRODUCTION: 1.1.Report Description; 1.2.Key Market Segments; 1.3.Key Benefits; 1.4.Research Methodology; 1.4.1.Primary Research; 1.4.2.Secondary Research; 1.4.3.Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY: 2.1.CXO Perspective
CHAPTER 3: MARKET LANDSCAPE: 3.1.Market Definition and Scope; 3.2.Key Findings; 3.2.1.Top Investment Pockets; 3.2.2.Top Winning Strategies; 3.3.Porter's Five Forces Analysis; 3.3.1.Bargaining Power of Suppliers; 3.3.2.Threat of New Entrants; 3.3.3.Threat of Substitutes; 3.3.4.Competitive Rivalry; 3.3.5.Bargaining Power among Buyers; 3.4.Market Share Analysis/Top Player Positioning; 3.4.1.Market Share Analysis/Top Player Positioning 2020; 3.5.Market Dynamics; 3.5.1.Drivers; 3.5.2.Restraints; 3.5.3.Opportunities; 3.6. COVID-19 Impact Analysis
CHAPTER 4: BRAIN HEALTH SUPPLEMENT MARKET, BY AGE GROUP: 4.1.Market Overview; 4.1.1Market Size and Forecast, By Age Group; 4.2.Children; 4.2.1.Key Market Trends, Growth Factors and Opportunities; 4.2.2.Market Size and Forecast, By Region; 4.2.3.Market Share Analysis, By Country; 4.3.Adults; 4.3.1.Key Market Trends, Growth Factors and Opportunities; 4.3.2.Market Size and Forecast, By Region; 4.3.3.Market Share Analysis, By Country; 4.4.Elderly; 4.4.1.Key Market Trends, Growth Factors and Opportunities; 4.4.2.Market Size and Forecast, By Region; 4.4.3.Market Share Analysis, By Country
CHAPTER 5: BRAIN HEALTH SUPPLEMENT MARKET, BY PRODUCT: 5.1.Market Overview; 5.1.1Market Size and Forecast, By Product; 5.2.Herbal Extract; 5.2.1.Key Market Trends, Growth Factors and Opportunities; 5.2.2.Market Size and Forecast, By Region; 5.2.3.Market Share Analysis, By Country; 5.2.4.Ginseng; 5.2.4.1.Market Size and Forecast; 5.2.5.Ginkgo Biloba; 5.2.5.1.Market Size and Forecast; 5.2.6.Curcumin; 5.2.6.1.Market Size and Forecast; 5.2.7.Lions Mane; 5.2.7.1.Market Size and Forecast; 5.2.8.Bacopa Monnieri; 5.2.8.1.Market Size and Forecast; 5.2.9.Other herbal extracts; 5.2.9.1.Market Size and Forecast; 5.3.Vitamins And Minerals; 5.3.1.Key Market Trends, Growth Factors and Opportunities; 5.3.2.Market Size and Forecast, By Region; 5.3.3.Market Share Analysis, By Country; 5.3.4.Vitamin B; 5.3.4.1.Market Size and Forecast; 5.3.5.Vitamin C and E; 5.3.5.1.Market Size and Forecast; 5.3.6.Other vitamins and minerals; 5.3.6.1.Market Size and Forecast; 5.4.Natural Molecules; 5.4.1.Key Market Trends, Growth Factors and Opportunities; 5.4.2.Market Size and Forecast, By Region; 5.4.3.Market Share Analysis, By Country; 5.4.4.Acetyl-L-carnitine; 5.4.4.1.Market Size and Forecast; 5.4.5.Alpha GPC; 5.4.5.1.Market Size and Forecast; 5.4.6.Citicoline; 5.4.6.1.Market Size and Forecast; 5.4.7.Docosahexaenoic Acid (DHA); 5.4.7.1.Market Size and Forecast; 5.4.8.Huperzine-AHuperzine-AHuperzine-A; 5.4.8.1.Market Size and Forecast; 5.4.9.Other natural molecules; 5.4.9.1.Market Size and Forecast
CHAPTER 6: BRAIN HEALTH SUPPLEMENT MARKET, BY APPLICATION: 6.1.Market Overview; 6.1.1Market Size and Forecast, By Application; 6.2.Memory Enhancement; 6.2.1.Key Market Trends, Growth Factors and Opportunities; 6.2.2.Market Size and Forecast, By Region; 6.2.3.Market Share Analysis, By Country; 6.3.Mood And Depression; 6.3.1.Key Market Trends, Growth Factors and Opportunities; 6.3.2.Market Size and Forecast, By Region; 6.3.3.Market Share Analysis, By Country; 6.4.Attention And Focus; 6.4.1.Key Market Trends, Growth Factors and Opportunities; 6.4.2.Market Size and Forecast, By Region; 6.4.3.Market Share Analysis, By Country; 6.5.Longevity And Anti-aging; 6.5.1.Key Market Trends, Growth Factors and Opportunities; 6.5.2.Market Size and Forecast, By Region; 6.5.3.Market Share Analysis, By Country; 6.6.Sleep And Recovery; 6.6.1.Key Market Trends, Growth Factors and Opportunities; 6.6.2.Market Size and Forecast, By Region; 6.6.3.Market Share Analysis, By Country; 6.7.Anxiety; 6.7.1.Key Market Trends, Growth Factors and Opportunities; 6.7.2.Market Size and Forecast, By Region; 6.7.3.Market Share Analysis, By Country
CHAPTER 7: BRAIN HEALTH SUPPLEMENT MARKET, BY SUPPLEMENT FORM: 7.1.Market Overview; 7.1.1Market Size and Forecast, By Supplement Form; 7.2.Tablets; 7.2.1.Key Market Trends, Growth Factors and Opportunities; 7.2.2.Market Size and Forecast, By Region; 7.2.3.Market Share Analysis, By Country; 7.3.Capsules; 7.3.1.Key Market Trends, Growth Factors and Opportunities; 7.3.2.Market Size and Forecast, By Region; 7.3.3.Market Share Analysis, By Country; 7.4.Others; 7.4.1.Key Market Trends, Growth Factors and Opportunities; 7.4.2.Market Size and Forecast, By Region; 7.4.3.Market Share Analysis, By Country
CHAPTER 8: BRAIN HEALTH SUPPLEMENT MARKET, BY SALES CHANNEL: 8.1.Market Overview; 8.1.1Market Size and Forecast, By Sales Channel; 8.2.Supermarkets And Hypermarkets; 8.2.1.Key Market Trends, Growth Factors and Opportunities; 8.2.2.Market Size and Forecast, By Region; 8.2.3.Market Share Analysis, By Country; 8.3.Drug Stores; 8.3.1.Key Market Trends, Growth Factors and Opportunities; 8.3.2.Market Size and Forecast, By Region; 8.3.3.Market Share Analysis, By Country; 8.4.Online Stores; 8.4.1.Key Market Trends, Growth Factors and Opportunities; 8.4.2.Market Size and Forecast, By Region; 8.4.3.Market Share Analysis, By Country; 8.5.Others; 8.5.1.Key Market Trends, Growth Factors and Opportunities; 8.5.2.Market Size and Forecast, By Region; 8.5.3.Market Share Analysis, By Country
CHAPTER 9: BRAIN HEALTH SUPPLEMENT MARKET, BY REGION: 9.1.Market Overview; 9.1.1Market Size and Forecast, By Region; 9.2.Europe; 9.2.1.Key Market Trends and Opportunities; 9.2.2.Market Size and Forecast, By Age Group; 9.2.3.Market Size and Forecast, By Product; 9.2.4.Market Size and Forecast, By Application; 9.2.5.Market Size and Forecast, By Supplement Form; 9.2.6.Market Size and Forecast, By Sales Channel; 9.2.7.Market Size and Forecast, By Country; 9.2.8.France Brain Health Supplement Market; 9.2.8.1.Market Size and Forecast, By Age Group; 9.2.8.2.Market Size and Forecast, By Product; 9.2.8.3.Market Size and Forecast, By Application; 9.2.8.4.Market Size and Forecast, By Supplement Form; 9.2.8.5.Market Size and Forecast, By Sales Channel; 9.2.9.Germany Brain Health Supplement Market; 9.2.9.1.Market Size and Forecast, By Age Group; 9.2.9.2.Market Size and Forecast, By Product; 9.2.9.3.Market Size and Forecast, By Application; 9.2.9.4.Market Size and Forecast, By Supplement Form; 9.2.9.5.Market Size and Forecast, By Sales Channel; 9.2.10.Italy Brain Health Supplement Market; 9.2.10.1.Market Size and Forecast, By Age Group; 9.2.10.2.Market Size and Forecast, By Product; 9.2.10.3.Market Size and Forecast, By Application; 9.2.10.4.Market Size and Forecast, By Supplement Form; 9.2.10.5.Market Size and Forecast, By Sales Channel; 9.2.11.Spain Brain Health Supplement Market; 9.2.11.1.Market Size and Forecast, By Age Group; 9.2.11.2.Market Size and Forecast, By Product; 9.2.11.3.Market Size and Forecast, By Application; 9.2.11.4.Market Size and Forecast, By Supplement Form; 9.2.11.5.Market Size and Forecast, By Sales Channel; 9.2.12.U.K Brain Health Supplement Market; 9.2.12.1.Market Size and Forecast, By Age Group; 9.2.12.2.Market Size and Forecast, By Product; 9.2.12.3.Market Size and Forecast, By Application; 9.2.12.4.Market Size and Forecast, By Supplement Form; 9.2.12.5.Market Size and Forecast, By Sales Channel; 9.2.13.Rest Of Europe Brain Health Supplement Market; 9.2.13.1.Market Size and Forecast, By Age Group; 9.2.13.2.Market Size and Forecast, By Product; 9.2.13.3.Market Size and Forecast, By Application; 9.2.13.4.Market Size and Forecast, By Supplement Form; 9.2.13.5.Market Size and Forecast, By Sales Channel; 9.3.Asia-Pacific; 9.3.1.Key Market Trends and Opportunities; 9.3.2.Market Size and Forecast, By Age Group; 9.3.3.Market Size and Forecast, By Product; 9.3.4.Market Size and Forecast, By Application; 9.3.5.Market Size and Forecast, By Supplement Form; 9.3.6.Market Size and Forecast, By Sales Channel; 9.3.7.Market Size and Forecast, By Country; 9.3.8.China Brain Health Supplement Market; 9.3.8.1.Market Size and Forecast, By Age Group; 9.3.8.2.Market Size and Forecast, By Product; 9.3.8.3.Market Size and Forecast, By Application; 9.3.8.4.Market Size and Forecast, By Supplement Form; 9.3.8.5.Market Size and Forecast, By Sales Channel; 9.3.9.Japan Brain Health Supplement Market; 9.3.9.1.Market Size and Forecast, By Age Group; 9.3.9.2.Market Size and Forecast, By Product; 9.3.9.3.Market Size and Forecast, By Application; 9.3.9.4.Market Size and Forecast, By Supplement Form; 9.3.9.5.Market Size and Forecast, By Sales Channel; 9.3.10.India Brain Health Supplement Market; 9.3.10.1.Market Size and Forecast, By Age Group; 9.3.10.2.Market Size and Forecast, By Product; 9.3.10.3.Market Size and Forecast, By Application; 9.3.10.4.Market Size and Forecast, By Supplement Form; 9.3.10.5.Market Size and Forecast, By Sales Channel; 9.3.11.South Korea Brain Health Supplement Market; 9.3.11.1.Market Size and Forecast, By Age Group; 9.3.11.2.Market Size and Forecast, By Product; 9.3.11.3.Market Size and Forecast, By Application; 9.3.11.4.Market Size and Forecast, By Supplement Form; 9.3.11.5.Market Size and Forecast, By Sales Channel; 9.3.12.Australia Brain Health Supplement Market; 9.3.12.1.Market Size and Forecast, By Age Group; 9.3.12.2.Market Size and Forecast, By Product; 9.3.12.3.Market Size and Forecast, By Application; 9.3.12.4.Market Size and Forecast, By Supplement Form; 9.3.12.5.Market Size and Forecast, By Sales Channel; 9.3.13.Rest of Asia Pacific Brain Health Supplement Market; 9.3.13.1.Market Size and Forecast, By Age Group; 9.3.13.2.Market Size and Forecast, By Product; 9.3.13.3.Market Size and Forecast, By Application; 9.3.13.4.Market Size and Forecast, By Supplement Form; 9.3.13.5.Market Size and Forecast, By Sales Channel; 9.4.North America; 9.4.1.Key Market Trends and Opportunities; 9.4.2.Market Size and Forecast, By Age Group; 9.4.3.Market Size and Forecast, By Product; 9.4.4.Market Size and Forecast, By Application; 9.4.5.Market Size and Forecast, By Supplement Form; 9.4.6.Market Size and Forecast, By Sales Channel; 9.4.7.Market Size and Forecast, By Country; 9.4.8.United States Brain Health Supplement Market; 9.4.8.1.Market Size and Forecast, By Age Group; 9.4.8.2.Market Size and Forecast, By Product; 9.4.8.3.Market Size and Forecast, By Application; 9.4.8.4.Market Size and Forecast, By Supplement Form; 9.4.8.5.Market Size and Forecast, By Sales Channel; 9.4.9.Canada Brain Health Supplement Market; 9.4.9.1.Market Size and Forecast, By Age Group; 9.4.9.2.Market Size and Forecast, By Product; 9.4.9.3.Market Size and Forecast, By Application; 9.4.9.4.Market Size and Forecast, By Supplement Form; 9.4.9.5.Market Size and Forecast, By Sales Channel; 9.4.10.Mexico Brain Health Supplement Market; 9.4.10.1.Market Size and Forecast, By Age Group; 9.4.10.2.Market Size and Forecast, By Product; 9.4.10.3.Market Size and Forecast, By Application; 9.4.10.4.Market Size and Forecast, By Supplement Form; 9.4.10.5.Market Size and Forecast, By Sales Channel; 9.5.LAMEA; 9.5.1.Key Market Trends and Opportunities; 9.5.2.Market Size and Forecast, By Age Group; 9.5.3.Market Size and Forecast, By Product; 9.5.4.Market Size and Forecast, By Application; 9.5.5.Market Size and Forecast, By Supplement Form; 9.5.6.Market Size and Forecast, By Sales Channel; 9.5.7.Market Size and Forecast, By Country; 9.5.8.Brazil Brain Health Supplement Market; 9.5.8.1.Market Size and Forecast, By Age Group; 9.5.8.2.Market Size and Forecast, By Product; 9.5.8.3.Market Size and Forecast, By Application; 9.5.8.4.Market Size and Forecast, By Supplement Form; 9.5.8.5.Market Size and Forecast, By Sales Channel; 9.5.9.South Africa, Brain Health Supplement Market; 9.5.9.1.Market Size and Forecast, By Age Group; 9.5.9.2.Market Size and Forecast, By Product; 9.5.9.3.Market Size and Forecast, By Application; 9.5.9.4.Market Size and Forecast, By Supplement Form; 9.5.9.5.Market Size and Forecast, By Sales Channel; 9.5.10.Saudi Arabia Brain Health Supplement Market; 9.5.10.1.Market Size and Forecast, By Age Group; 9.5.10.2.Market Size and Forecast, By Product; 9.5.10.3.Market Size and Forecast, By Application; 9.5.10.4.Market Size and Forecast, By Supplement Form; 9.5.10.5.Market Size and Forecast, By Sales Channel; 9.5.11.Rest of LAMEA Brain Health Supplement Market; 9.5.11.1.Market Size and Forecast, By Age Group; 9.5.11.2.Market Size and Forecast, By Product; 9.5.11.3.Market Size and Forecast, By Application; 9.5.11.4.Market Size and Forecast, By Supplement Form; 9.5.11.5.Market Size and Forecast, By Sales Channel
CHAPTER 10: COMPANY PROFILES: 10.1.Accelerated Intelligence Inc.; 10.1.1.Company Overview; 10.1.2.Key Executives; 10.1.3.Company snapshot; 10.1.4.Operating business segments; 10.1.5.Product portfolio; 10.1.6.Business Performance; 10.1.7.Key Strategic Moves and Developments; 10.2.AlternaScript LLC; 10.2.1.Company Overview; 10.2.2.Key Executives; 10.2.3.Company snapshot; 10.2.4.Operating business segments; 10.2.5.Product portfolio; 10.2.6.Business Performance; 10.2.7.Key Strategic Moves and Developments; 10.3.Natroll, LLC; 10.3.1.Company Overview; 10.3.2.Key Executives; 10.3.3.Company snapshot; 10.3.4.Operating business segments; 10.3.5.Product portfolio; 10.3.6.Business Performance; 10.3.7.Key Strategic Moves and Developments; 10.4.HVMN Inc.; 10.4.1.Company Overview; 10.4.2.Key Executives; 10.4.3.Company snapshot; 10.4.4.Operating business segments; 10.4.5.Product portfolio; 10.4.6.Business Performance; 10.4.7.Key Strategic Moves and Developments; 10.5.KeyView Labs, Inc.; 10.5.1.Company Overview; 10.5.2.Key Executives; 10.5.3.Company snapshot; 10.5.4.Operating business segments; 10.5.5.Product portfolio; 10.5.6.Business Performance; 10.5.7.Key Strategic Moves and Developments; 10.6.Liquid Health, Inc.; 10.6.1.Company Overview; 10.6.2.Key Executives; 10.6.3.Company snapshot; 10.6.4.Operating business segments; 10.6.5.Product portfolio; 10.6.6.Business Performance; 10.6.7.Key Strategic Moves and Developments; 10.7.Natural Factors Nutritional Products Ltd.; 10.7.1.Company Overview; 10.7.2.Key Executives; 10.7.3.Company snapshot; 10.7.4.Operating business segments; 10.7.5.Product portfolio; 10.7.6.Business Performance; 10.7.7.Key Strategic Moves and Developments; 10.8.Onnit Labs, LLC; 10.8.1.Company Overview; 10.8.2.Key Executives; 10.8.3.Company snapshot; 10.8.4.Operating business segments; 10.8.5.Product portfolio; 10.8.6.Business Performance; 10.8.7.Key Strategic Moves and Developments; 10.9.Purelife Bioscience Co., Ltd.; 10.9.1.Company Overview; 10.9.2.Key Executives; 10.9.3.Company snapshot; 10.9.4.Operating business segments; 10.9.5.Product portfolio; 10.9.6.Business Performance; 10.9.7.Key Strategic Moves and Developments; 10.10.Quincy Bioscience, LLC.; 10.10.1.Company Overview; 10.10.2.Key Executives; 10.10.3.Company snapshot; 10.10.4.Operating business segments; 10.10.5.Product portfolio; 10.10.6.Business Performance; 10.10.7.Key Strategic Moves and Developments
LIST OF TABLES: TABLE 1.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 2.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR CHILDREN, BY REGION, 2020-2030 ($MILLION); TABLE 3.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR ADULTS, BY REGION, 2020-2030 ($MILLION); TABLE 4.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR ELDERLY, BY REGION, 2020-2030 ($MILLION); TABLE 5.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION); TABLE 6.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR HERBAL EXTRACT, BY REGION, 2020-2030 ($MILLION); TABLE 7.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR VITAMINS AND MINERALS, BY REGION, 2020-2030 ($MILLION); TABLE 8.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR NATURAL MOLECULES, BY REGION, 2020-2030 ($MILLION); TABLE 9.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET, BY APPLICATION, 2020-2030 ($MILLION); TABLE 10.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR MEMORY ENHANCEMENT, BY REGION, 2020-2030 ($MILLION); TABLE 11.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR MOOD AND DEPRESSION, BY REGION, 2020-2030 ($MILLION); TABLE 12.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR ATTENTION AND FOCUS, BY REGION, 2020-2030 ($MILLION); TABLE 13.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR LONGEVITY AND ANTI-AGING, BY REGION, 2020-2030 ($MILLION); TABLE 14.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR SLEEP AND RECOVERY, BY REGION, 2020-2030 ($MILLION); TABLE 15.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR ANXIETY, BY REGION, 2020-2030 ($MILLION); TABLE 16.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 17.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR TABLETS, BY REGION, 2020-2030 ($MILLION); TABLE 18.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR CAPSULES, BY REGION, 2020-2030 ($MILLION); TABLE 19.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION); TABLE 20.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 21.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR SUPERMARKETS AND HYPERMARKETS, BY REGION, 2020-2030 ($MILLION); TABLE 22.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR DRUG STORES, BY REGION, 2020-2030 ($MILLION); TABLE 23.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR ONLINE STORES, BY REGION, 2020-2030 ($MILLION); TABLE 24.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION); TABLE 25.GLOBAL BRAIN HEALTH SUPPLEMENT MARKET, BY REGION, 2020-2030 ($MILLION); TABLE 26.EUROPE BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 27.EUROPE BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 28.EUROPE BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 29.EUROPE BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 30.EUROPE BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 31.FRANCE BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 32.FRANCE BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 33.FRANCE BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 34.FRANCE BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 35.FRANCE BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 36.GERMANY BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 37.GERMANY BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 38.GERMANY BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 39.GERMANY BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 40.GERMANY BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 41.ITALY BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 42.ITALY BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 43.ITALY BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 44.ITALY BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 45.ITALY BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 46.SPAIN BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 47.SPAIN BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 48.SPAIN BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 49.SPAIN BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 50.SPAIN BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 51.UNITED KINGDOM BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 52.UNITED KINGDOM BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 53.UNITED KINGDOM BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 54.UNITED KINGDOM BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 55.UNITED KINGDOM BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 56.REST OF EUROPE BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 57.REST OF EUROPE BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 58.REST OF EUROPE BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 59.REST OF EUROPE BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 60.REST OF EUROPE BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 61.ASIA-PACIFIC BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 62.ASIA-PACIFIC BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 63.ASIA-PACIFIC BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 64.ASIA-PACIFIC BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 65.ASIA-PACIFIC BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 66.CHINA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 67.CHINA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 68.CHINA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 69.CHINA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 70.CHINA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 71.JAPAN BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 72.JAPAN BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 73.JAPAN BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 74.JAPAN BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 75.JAPAN BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 76.INDIA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 77.INDIA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 78.INDIA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 79.INDIA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 80.INDIA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 81.SOUTH KOREA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 82.SOUTH KOREA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 83.SOUTH KOREA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 84.SOUTH KOREA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 85.SOUTH KOREA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 86.AUSTRALIA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 87.AUSTRALIA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 88.AUSTRALIA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 89.AUSTRALIA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 90.AUSTRALIA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 91.REST OF ASIA PACIFIC BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 92.REST OF ASIA PACIFIC BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 93.REST OF ASIA PACIFIC BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 94.REST OF ASIA PACIFIC BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 95.REST OF ASIA PACIFIC BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 96.NORTH AMERICA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 97.NORTH AMERICA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 98.NORTH AMERICA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 99.NORTH AMERICA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 100.NORTH AMERICA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 101.UNITED STATES BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 102.UNITED STATES BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 103.UNITED STATES BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 104.UNITED STATES BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 105.UNITED STATES BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 106.CANADA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 107.CANADA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 108.CANADA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 109.CANADA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 110.CANADA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 111.MEXICO BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 112.MEXICO BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 113.MEXICO BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 114.MEXICO BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 115.MEXICO BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 116.LAMEA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 117.LAMEA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 118.LAMEA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 119.LAMEA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 120.LAMEA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 121.BRAZIL BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 122.BRAZIL BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 123.BRAZIL BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 124.BRAZIL BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 125.BRAZIL BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 126.SOUTH AFRICA, BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 127.SOUTH AFRICA, BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 128.SOUTH AFRICA, BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 129.SOUTH AFRICA, BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 130.SOUTH AFRICA, BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 131.SAUDI ARABIA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 132.SAUDI ARABIA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 133.SAUDI ARABIA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 134.SAUDI ARABIA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 135.SAUDI ARABIA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 136.REST OF LAMEA BRAIN HEALTH SUPPLEMENT, BY AGE GROUP, 2020-2030 ($MILLION); TABLE 137.REST OF LAMEA BRAIN HEALTH SUPPLEMENT, BY PRODUCT, 2020-2030 ($MILLION); TABLE 138.REST OF LAMEA BRAIN HEALTH SUPPLEMENT, BY APPLICATION, 2020-2030 ($MILLION); TABLE 139.REST OF LAMEA BRAIN HEALTH SUPPLEMENT, BY SUPPLEMENT FORM, 2020-2030 ($MILLION); TABLE 140.REST OF LAMEA BRAIN HEALTH SUPPLEMENT, BY SALES CHANNEL, 2020-2030 ($MILLION); TABLE 141.ACCELERATED INTELLIGENCE INC.: KEY EXECUTIVES; TABLE 142.ACCELERATED INTELLIGENCE INC.: COMPANY SNAPSHOT; TABLE 143.ACCELERATED INTELLIGENCE INC.: OPERATING SEGMENTS; TABLE 144.ACCELERATED INTELLIGENCE INC.: PRODUCT PORTFOLIO; TABLE 145.ACCELERATED INTELLIGENCE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 146.ALTERNASCRIPT LLC: KEY EXECUTIVES; TABLE 147.ALTERNASCRIPT LLC: COMPANY SNAPSHOT; TABLE 148.ALTERNASCRIPT LLC: OPERATING SEGMENTS; TABLE 149.ALTERNASCRIPT LLC: PRODUCT PORTFOLIO; TABLE 150.ALTERNASCRIPT LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 151.NATROLL, LLC: KEY EXECUTIVES; TABLE 152.NATROLL, LLC: COMPANY SNAPSHOT; TABLE 153.NATROLL, LLC: OPERATING SEGMENTS; TABLE 154.NATROLL, LLC: PRODUCT PORTFOLIO; TABLE 155.NATROLL, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 156.HVMN INC.: KEY EXECUTIVES; TABLE 157.HVMN INC.: COMPANY SNAPSHOT; TABLE 158.HVMN INC.: OPERATING SEGMENTS; TABLE 159.HVMN INC.: PRODUCT PORTFOLIO; TABLE 160.HVMN INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 161.KEYVIEW LABS, INC.: KEY EXECUTIVES; TABLE 162.KEYVIEW LABS, INC.: COMPANY SNAPSHOT; TABLE 163.KEYVIEW LABS, INC.: OPERATING SEGMENTS; TABLE 164.KEYVIEW LABS, INC.: PRODUCT PORTFOLIO; TABLE 165.KEYVIEW LABS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 166.LIQUID HEALTH, INC.: KEY EXECUTIVES; TABLE 167.LIQUID HEALTH, INC.: COMPANY SNAPSHOT; TABLE 168.LIQUID HEALTH, INC.: OPERATING SEGMENTS; TABLE 169.LIQUID HEALTH, INC.: PRODUCT PORTFOLIO; TABLE 170.LIQUID HEALTH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 171.NATURAL FACTORS NUTRITIONAL PRODUCTS LTD.: KEY EXECUTIVES; TABLE 172.NATURAL FACTORS NUTRITIONAL PRODUCTS LTD.: COMPANY SNAPSHOT; TABLE 173.NATURAL FACTORS NUTRITIONAL PRODUCTS LTD.: OPERATING SEGMENTS; TABLE 174.NATURAL FACTORS NUTRITIONAL PRODUCTS LTD.: PRODUCT PORTFOLIO; TABLE 175.NATURAL FACTORS NUTRITIONAL PR

Pricing

Currency Rates

Single User Email from Publisher $6,168
Data Pack/Excel E-mail From Publisher $4,125
PDF (1-5 users) $6,929
Global Site License Email from Publisher $10,663

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now